Otsuka Long-Evans Tokushima Fatty (OLETF) rat is not a suitable animal model for the study of angiopathic diabetic retinopathy

International Journal of Tissue Reactions

Volumn 27, Issue 2, 2005, Pages 59-62

  Matsuura, T ^a   Yamagishi, S ^b   Kodama, Y ^c   Shibata, R ^b   Ueda, S ^b   Narama, I ^a  

^a SETSUNAN UNIVERSITY   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c HIROSHIMA INTERNATIONAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; TRYPSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DIABETIC RETINOPATHY; ELECTRORETINOGRAPHY; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OSCILLATORY POTENTIAL; RAT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ANIMALS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC RETINOPATHY; DISEASE MODELS, ANIMAL; RATS; RATS, INBRED OLETF; RATS, LONG-EVANS; RECEPTOR, CHOLECYSTOKININ A; RETINA; RETINAL VESSELS;

ANIMALIA;

EID: 22144463198     PISSN: 02500868     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Bi S., Moran T.H. Actions of CCK in the controls of food intake and body weight: Lessons from the CCK-A receptor deficient OLETF rat. Neuropeptide, 36, 171, 2002.
2. Kawano K. Hirashima T., Mori S., Natori T. OLETF (Otsuka Long-Evans Tokushima Fatty rat: A new NIDDM rat strain. Diabetes Res. Clin. Pract., 24, S317, 1994.
3. Tsuchida K., Makita Z., Yamagishi S., et al. Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195. Diabetologia, 42, 579, 1999.
4. Yamagishi S., Koga K., Inagaki Y., et al. Dilazep hydrochloride, an antiplatelet drug, prevents progression of diabetic nephropathy in Otsuka Long-Evans Tokushima Fatty rats. Drugs Exp. Clin. Res., 28, 221, 2002.
5. Koga K., Yamagishi S., Takeuchi M., et al. CS-866, a new angiotensin II type 1 receptor antagonist, ameliorates glomerular anionic site loss and prevents progression of diabetic nephropathy in Otsuka Long-Evans Tokushima Fatty rats. Mol. Med., 8, 591, 2002.
6. Segawa Y., Shirao Y., Yamagishi S., et al. Upregulation of retinal vascular endothelial growth factor mRNAs in spontaneously diabetic rats without ophthalmoscopic retinopathy. Ophthalmic. Res., 30, 333, 1998.
7. Ashton N. Studies of the retinal capillaries in relation to diabetic and other retinopathies. Br J. Ophthalmol., 47, 521, 1963.
8. Cohen A.M., Michaelson I.C., Yanko, L. Retinopathy in rats with disturbed carbohydrate metabolism following a high sucrose diet. Am. J. Ophthalmol., 73, 863, 1973.
9. Frank R.N. On the pathogenesis of diabetic retinopathy. A 1990 update. Ophthalmology, 98, 586, 1991.
10. Yamagishi S., Kobayashi K., Yamamoto H. Vascular pericytes not only regulate growth, but also preserve prostacyclin-producing ability and protect against lipid peroxide-induced injury of co-cultured endothelial cells. Biochem. Biophys. Res. Commun., 190, 418, 1993.
11. Yamagishi S., Hsu C.C., Kobayashi K., Yamamoto H. Endothelin 1 mediates endothelial cell-dependent proliferation of vascular pericytes. Biochem. Biophys. Res. Commun., 191, 840, 1993.
12. Yamagishi S., Hsu C.C., Taniguchi M., et al. Receptor-mediated toxicity to pericytes of advanced glycosylation end products: A possible mechanism of pericyte loss in diabetic microangiopathy. Biochem. Biophys. Res. Commun., 213, 681, 1995.
13. Yamagishi S., Yonekura H., Yamamoto Y., et al. Vascular endothelial growth factor acts as a pericyte mitogen under hypoxic conditions. Lab. Invest., 79, 501, 1999.
14. Yamagishi S., Amano S., Inagaki Y., et al. Advanced glycation end products-induced apoptosis and overexpression of vascular endothelial growth factor in bovine retinal pericytes. Biochem. Biophys. Res. Commun., 290, 973, 2002.
15. Yamagishi S., Okamoto T., Amano S., et al. Palmitate-induced apoptosis of microvascular endothelial cells and pericytes. Mol. Med., 8, 178, 2002.
16. 2 analogue, protects against advanced glycation end products-induced injury in cultured retinal pericytes. Mol. Med., 8, 547, 2002.
17. Yamagishi S., Inagaki Y., Amano S., et al. Pigment epithelium-derived factor protects cultured retinal pericytes from advanced glycation end product-induced injury through its anti-oxidative properties. Biochem. Biophys. Res. Commun., 296, 877, 2002.
18. Amano S., Yamagishi S., Kato N., et al. Sorbitol dehydrogenase overexpression potentiates glucose toxicity to cultured retinal pericytes. Biochem. Biophys. Res. Commun., 299, 183, 2002.
19. Mizutani M., Kern T.S., Lorenzi M. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J. Clin. Invest., 97, 2883, 1996.
20. Zheng L., Szabo C., Kern T.S. Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-B. Diabetes, 53, 2960, 2004.